Free Trial

Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 365 Shares of Stock

Docusign logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • DocuSign director Teresa Briggs sold 365 shares on May 29 at an average price of $50.04, totaling about $18,265. The sale was made under a pre-arranged Rule 10b5-1 plan and reduced her holdings by 3.43%.
  • The stock was down 3.4% in Tuesday trading, closing at $55.10 amid above-average volume. DocuSign’s shares have ranged from a 52-week low of $40.16 to a high of $94.67.
  • DocuSign recently beat quarterly expectations, reporting EPS of $1.01 versus $0.95 expected and revenue of $836.86 million, up 7.8% year over year. The company also authorized a $2 billion stock buyback, while analysts currently rate the stock a consensus Hold.
  • Interested in Docusign? Here are five stocks we like better.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Teresa Briggs sold 365 shares of the stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $50.04, for a total transaction of $18,264.60. Following the completion of the transaction, the director owned 10,263 shares in the company, valued at $513,560.52. The trade was a 3.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Down 3.4%

DOCU traded down $1.92 during trading on Tuesday, hitting $55.10. The company's stock had a trading volume of 4,876,948 shares, compared to its average volume of 4,341,708. Docusign Inc. has a one year low of $40.16 and a one year high of $94.67. The firm has a market cap of $10.71 billion, a PE ratio of 37.23, a P/E/G ratio of 2.01 and a beta of 0.88. The business's 50 day simple moving average is $47.41 and its 200-day simple moving average is $54.53.

Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business had revenue of $836.86 million for the quarter, compared to the consensus estimate of $828.23 million. During the same period last year, the firm earned $0.86 earnings per share. The company's quarterly revenue was up 7.8% on a year-over-year basis. Equities research analysts expect that Docusign Inc. will post 1.75 EPS for the current fiscal year.

Docusign declared that its board has authorized a stock buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 21% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on DOCU shares. UBS Group decreased their price target on shares of Docusign from $75.00 to $54.00 and set a "neutral" rating on the stock in a research report on Wednesday, March 18th. Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a research report on Tuesday, March 10th. JPMorgan Chase & Co. decreased their price target on shares of Docusign from $78.00 to $65.00 and set a "neutral" rating on the stock in a research report on Wednesday, March 18th. Citigroup downgraded shares of Docusign from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $99.00 to $50.00 in a research report on Friday, April 10th. Finally, Weiss Ratings downgraded shares of Docusign from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, April 15th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $61.40.

Read Our Latest Report on DOCU

Institutional Trading of Docusign

Several institutional investors and hedge funds have recently modified their holdings of DOCU. Central Pacific Bank Trust Division bought a new stake in shares of Docusign during the 4th quarter valued at $25,000. Modus Advisors LLC bought a new stake in shares of Docusign during the 4th quarter valued at $27,000. Torren Management LLC bought a new stake in shares of Docusign during the 4th quarter valued at $28,000. Aventura Private Wealth LLC bought a new stake in shares of Docusign during the 4th quarter valued at $30,000. Finally, True Wealth Design LLC raised its position in shares of Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company's stock valued at $30,000 after purchasing an additional 222 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

About Docusign

(Get Free Report)

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Recommended Stories

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines